The history of Viagra, formerly marketed by copyright, presents a intricate case study for backers considering the drug sector. Although its initial success and impact of countless in sales, the exclusivity lapse has opened the way for competing medications, greatly eroding earnings opportunities. This change raises concerns about the future viabil